J. Scharenberg

发表

In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system

D. de Korte, P. F. van der Meer, J. de Wildt-Eggen, 2010, Vox sanguinis.

A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure

J. Zwaginga, A. Brand, D. de Korte, 2015, Transfusion.

Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls.

A. Peña, G. Bouma, S. Meuwissen, 1995, Scandinavian journal of gastroenterology.

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.

S. Rodenhuis, J. Sein, A. Hekman, 1993, British Journal of Cancer.

Persistent augmentation of natural-killer-and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose

C. Meijer, P. Palmer, C. Franks, 1994, Cancer Immunology, Immunotherapy.

Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2.

J. Baars, C. Polman, J. Heimans, 1991, Surgical neurology.

Functional and mechanistic studies on the toxicity of deoxyguanosine for the in vitro proliferation and differentiation of human peripheral blood B lymphocytes

M. Durán, B. Zegers, G. Staal, 1986, European journal of immunology.

The mechanism of deoxyguanosine mediated toxicity in proliferating human peripheral blood T lymphocytes.

G. Rijkers, B. Zegers, J. Scharenberg, 1989 .

Expression of Deoxyadenosine and Deoxyguanosine Toxicity at Different Stages of Lymphocyte Activation

G. Rijkers, B. Zegers, J. Scharenberg, 1988, Scandinavian journal of immunology.

Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages.

M. Durán, B. Zegers, G. Staal, 1988, International journal of immunopharmacology.

The inhibitory effect of deoxyadenosine and deoxyguanosine on in vitro lymphocyte function are expressed at different stages of lymphocyte activation.

G. Staal, G. Rijkers, B. Zegers, 1986 .

Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.

S. K. Wadman, B. Zegers, G. Staal, 1986, Advances in experimental medicine and biology.

Flow cytometric measurement of CD62P (P‐selectin) expression on platelets: a multicenter optimization and standardization effort

Joyce Curvers, J. Heeremans, D. de Korte, 2008, Transfusion.

Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization.

F. Claas, A. ten Brinke, J. Zwaginga, 2018, Blood.

The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2.

C. Meijer, P. Palmer, C. Franks, 1994, European journal of cancer.

Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.

J. Akkerman, B. Zegers, G. Staal, 1990, International journal of immunopharmacology.

Abnormal Signal Transduction in a Patient with Severe Combined Immunodeficiency Disease

H. Neijens, J. V. Dongen, G. Rijkers, 1991, Pediatric Research.